Literature DB >> 9000374

Characterization of the Saccharomyces cerevisiae FCY1 gene encoding cytosine deaminase and its homologue FCA1 of Candida albicans.

P Erbs1, F Exinger, R Jund.   

Abstract

By functional complementation of a fcy1 null mutant of Saccharomyces cerevisiae, we have cloned and characterized the FCY1 gene, encoding cytosine deaminase in Saccharomyces cerevisiae, and its homologue FCA1, encoding cytosine deaminase in Candida albicans. Disruption of FCY1 resulted in high resistance to 5-fluorocytosine (10(-2) M) and in total loss of cytosine deaminase activity. By contrast the transformation by FCY1 or FCA1 of the haploid FCY1-disrupted host strain restored sensitivity to 5-fluorocytosine and allowed growth on cytosine, as a source of pyrimidine, or ammonium. FCA1 as opposed to FCY1 contains an intron. FCA1 and FCY1 encode respectively 150- and 158- residue proteins of 60% identity. Both Fcy1p and Fca1p share common motifs with cytidine and CMP deaminases, but homology with cytosine deaminase of E. coli could not be detected.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9000374     DOI: 10.1007/s002940050169

Source DB:  PubMed          Journal:  Curr Genet        ISSN: 0172-8083            Impact factor:   3.886


  14 in total

1.  Noninvasive quantitation of cytosine deaminase transgene expression in human tumor xenografts with in vivo magnetic resonance spectroscopy.

Authors:  L D Stegman; A Rehemtulla; B Beattie; E Kievit; T S Lawrence; R G Blasberg; J G Tjuvajev; B D Ross
Journal:  Proc Natl Acad Sci U S A       Date:  1999-08-17       Impact factor: 11.205

2.  Cytosine deamination and base excision repair cause R-loop-induced CAG repeat fragility and instability in Saccharomyces cerevisiae.

Authors:  Xiaofeng A Su; Catherine H Freudenreich
Journal:  Proc Natl Acad Sci U S A       Date:  2017-09-18       Impact factor: 11.205

3.  Molecular mechanisms of primary resistance to flucytosine in Candida albicans.

Authors:  William W Hope; Lydia Tabernero; David W Denning; Michael J Anderson
Journal:  Antimicrob Agents Chemother       Date:  2004-11       Impact factor: 5.191

4.  Regulation of amino acid, nucleotide, and phosphate metabolism in Saccharomyces cerevisiae.

Authors:  Per O Ljungdahl; Bertrand Daignan-Fornier
Journal:  Genetics       Date:  2012-03       Impact factor: 4.562

5.  Mutational analysis of flucytosine resistance in Candida glabrata.

Authors:  Thomas D Edlind; Santosh K Katiyar
Journal:  Antimicrob Agents Chemother       Date:  2010-09-07       Impact factor: 5.191

6.  Asymmetrical dose responses shape the evolutionary trade-off between antifungal resistance and nutrient use.

Authors:  Philippe C Després; Angel F Cisneros; Emilie M M Alexander; Ria Sonigara; Cynthia Gagné-Thivierge; Alexandre K Dubé; Christian R Landry
Journal:  Nat Ecol Evol       Date:  2022-09-01       Impact factor: 19.100

7.  A Ser29Leu substitution in the cytosine deaminase Fca1p is responsible for clade-specific flucytosine resistance in Candida dubliniensis.

Authors:  Brenda A McManus; Gary P Moran; Judy A Higgins; Derek J Sullivan; David C Coleman
Journal:  Antimicrob Agents Chemother       Date:  2009-08-24       Impact factor: 5.191

8.  A system for multilocus chromosomal integration and transformation-free selection marker rescue.

Authors:  Michael S Siddiqui; Atri Choksi; Christina D Smolke
Journal:  FEMS Yeast Res       Date:  2014-10-10       Impact factor: 2.796

9.  Oncolytic virotherapy for ovarian carcinomatosis using a replication-selective vaccinia virus armed with a yeast cytosine deaminase gene.

Authors:  S Chalikonda; M H Kivlen; M E O'Malley; X D Eric Dong; J A McCart; M C Gorry; X-Y Yin; C K Brown; H J Zeh; Z S Guo; D L Bartlett
Journal:  Cancer Gene Ther       Date:  2007-12-14       Impact factor: 5.987

10.  A diverse population of Cryptococcus gattii molecular type VGIII in southern Californian HIV/AIDS patients.

Authors:  Edmond J Byrnes; Wenjun Li; Ping Ren; Yonathan Lewit; Kerstin Voelz; James A Fraser; Fred S Dietrich; Robin C May; Sudha Chaturvedi; Sudha Chatuverdi; Vishnu Chaturvedi; Vishnu Chatuverdi; Joseph Heitman
Journal:  PLoS Pathog       Date:  2011-09-01       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.